1Stovring H, Andersen M, Beck- Nielsen H, et al. Rising prevalence of diabetes: evidence from a Danish pharmaco - epidemiological database. Lancet 2003;362(9383) :537 -538.
2Vigneri P, Frasca F, Sciacca L, et al. Diabetes and cancer. Endocr Relat Cancer 2009;16(4) : 1103 - 1123.
3Richardson LC, Pollack LA. Therapy insight influence of type 2 diabetes on the development, treatment and outcomes of cancer. Nat Clin Pract Oncol 2005 ;2 ( 1 ) :48 - 53.
7Barone BB, Yeh HC , Snyder CF,et al. Postoperative Mortality in Cancer Patients With Preexisting Diabetes: Systematic review and meta - analysis. Diabetes Care 2010;33(4) :931 -932.
6King H,Aubert RE,Herman WH.Global burden of diabetes,1995-2025:prevalence,numerical estimates,and projections.Diabetes Care,1998,21:1414-1431.
7Stovring H,Andersen M,Beck-Nielsen H,et al.Rising prevalence of diabetes:evidence from a Danish pharmacy-epidemiolngical database.Lancet,2003,362:537-538.
8Silverman DT,Schiffman M,Everhart J,et al.Diabetes mellitus,other medical conditions and familial history of cancer as risk factors for pancreatic cancer.Br J Cancer,1999,80:1830-1837.
9Yang YX,Hennessy S,Lewis JD.Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients.Gastroenterology,2004,127:1044-1050.
10Bayram A,Eksi F,Mehli M.Prevalence of hepatitis E virus antibodies in patients with chronic hepatitis B and chronic hepatitis C.Gastroenterology,2008,134:95-101.
9Weiderpass E, Gridtey G, Persson I, et at. Risk of endometriat andbreast cancer in patients with diabetes mellitus. Int J Cancer, 1997, 71 (3) :360.
10Richardson L C, Pollack L A. Therapy insight : influence of type 2 di- abetes on the devetopment, treatment and outcomes of cancer. Nat Clin Pract Oncot, 2005, 2(1):48.
